Hyperosmolar hyperglycemic state primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 29: Line 29:
** Possible out-of-home placement
** Possible out-of-home placement
** Never discontinue [[insulin]] during illness without contacting health care provider
** Never discontinue [[insulin]] during illness without contacting health care provider
** Having medication available to treat an infection
** Having [[medication]] available to treat an [[infection]]


==References==
==References==
Line 38: Line 38:
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Up-To-Date]]​
[[Category:Up-To-Date]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]

Latest revision as of 18:00, 17 October 2017

Hyperosmolar hyperglycemic state Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyperosmolar hyperglycemic state from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hyperosmolar hyperglycemic state primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hyperosmolar hyperglycemic state primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hyperosmolar hyperglycemic state primary prevention

CDC on Hyperosmolar hyperglycemic state primary prevention

Hyperosmolar hyperglycemic state primary prevention in the news

Blogs on Hyperosmolar hyperglycemic state primary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Hyperosmolar hyperglycemic state primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]

Overview

Effective measures for the primary prevention of hyperosmolar hyperglycemic state (HHS) include recognition of early signs of HHS, implementation of early and aggressive interventions (especially in patients with recurrent episodes of (HHS), tight glycemic control especially in patients with chronic illnesses, and education of patients and their family members.

Primary Prevention

Effective measures for the primary prevention of hyperosmolar hyperglycemic state include:[1][2][3][4]

  • Early recognition of inciting event:
  • Early intervention:
    • Enhanced and more frequent monitoring of blood glucose
    • Increased fluid intake
    • Seek advice from health care team
  • Aggressive intervention in patients with recurrent episodes:

References

  1. Vanelli M, Scarabello C, Fainardi V (2008). "Available tools for primary ketoacidosis prevention at diabetes diagnosis in children and adolescents. "The Parma campaign"". Acta Biomed. 79 (1): 73–8. PMID 18551826.
  2. "Management of Diabetic Ketoacidosis - American Family Physician".
  3. Zhou HC (1985). "[Preliminary studies of cardiac function in pre-eclamptic patients with echocardiography and systolic time intervals]". Zhonghua Fu Chan Ke Za Zhi (in Chinese). 20 (5): 266–9, 317. PMID 4085289.
  4. "www.aace.com" (PDF).

Template:WH Template:WS